Icoreconnect Common Stock Stock Key Fundamental Indicators
| ICCT Stock | USD 0 0.0009 81.82% |
As of the 24th of February, ICoreConnect retains the Market Risk Adjusted Performance of (6.11), downside deviation of 57.54, and Semi Deviation of 34.21. ICoreConnect technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the entity's future prices.
Analyzing historical trends in various income statement and balance sheet accounts from ICoreConnect's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting ICoreConnect's valuation are summarized below:iCoreConnect Common stock does not currently have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. ICoreConnect |
ICoreConnect 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ICoreConnect's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ICoreConnect.
| 11/26/2025 |
| 02/24/2026 |
If you would invest 0.00 in ICoreConnect on November 26, 2025 and sell it all today you would earn a total of 0.00 from holding iCoreConnect Common stock or generate 0.0% return on investment in ICoreConnect over 90 days. iCoreConnect Inc., a cloud-based software and technology company, provides cloud-based software products for the healthc... More
ICoreConnect Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ICoreConnect's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess iCoreConnect Common stock upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 57.54 | |||
| Information Ratio | 0.2775 | |||
| Maximum Drawdown | 540.0 | |||
| Value At Risk | (81.82) | |||
| Potential Upside | 400.0 |
ICoreConnect Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ICoreConnect's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ICoreConnect's standard deviation. In reality, there are many statistical measures that can use ICoreConnect historical prices to predict the future ICoreConnect's volatility.| Risk Adjusted Performance | 0.2259 | |||
| Jensen Alpha | 33.95 | |||
| Total Risk Alpha | 23.75 | |||
| Sortino Ratio | 0.583 | |||
| Treynor Ratio | (6.12) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ICoreConnect's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ICoreConnect February 24, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2259 | |||
| Market Risk Adjusted Performance | (6.11) | |||
| Mean Deviation | 73.59 | |||
| Semi Deviation | 34.21 | |||
| Downside Deviation | 57.54 | |||
| Coefficient Of Variation | 359.56 | |||
| Standard Deviation | 120.86 | |||
| Variance | 14608.3 | |||
| Information Ratio | 0.2775 | |||
| Jensen Alpha | 33.95 | |||
| Total Risk Alpha | 23.75 | |||
| Sortino Ratio | 0.583 | |||
| Treynor Ratio | (6.12) | |||
| Maximum Drawdown | 540.0 | |||
| Value At Risk | (81.82) | |||
| Potential Upside | 400.0 | |||
| Downside Variance | 3310.44 | |||
| Semi Variance | 1170.26 | |||
| Expected Short fall | (134.38) | |||
| Skewness | 2.51 | |||
| Kurtosis | 6.05 |
iCoreConnect Common stock Backtested Returns
ICoreConnect is out of control given 3 months investment horizon. iCoreConnect Common stock holds Efficiency (Sharpe) Ratio of 0.28, which attests that the company had a 0.28 % return per unit of risk over the last 3 months. We were able to break down twenty-eight different technical indicators, which can help you to evaluate if expected returns of 34.08% are justified by taking the suggested risk. Use iCoreConnect Common stock Semi Deviation of 34.21, market risk adjusted performance of (6.11), and Downside Deviation of 57.54 to evaluate company specific risk that cannot be diversified away. ICoreConnect holds a performance score of 21 on a scale of zero to a hundred. The firm retains a Market Volatility (i.e., Beta) of -5.49, which attests to a somewhat significant risk relative to the market. As returns on the market increase, returns on owning ICoreConnect are expected to decrease by larger amounts. On the other hand, during market turmoil, ICoreConnect is expected to outperform it. Use iCoreConnect Common stock maximum drawdown, as well as the relationship between the expected short fall and day median price , to analyze future returns on iCoreConnect Common stock.
Auto-correlation | -0.03 |
Very weak reverse predictability
iCoreConnect Common stock has very weak reverse predictability. Overlapping area represents the amount of predictability between ICoreConnect time series from 26th of November 2025 to 10th of January 2026 and 10th of January 2026 to 24th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of iCoreConnect Common stock price movement. The serial correlation of -0.03 indicates that only 3.0% of current ICoreConnect price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.03 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, iCoreConnect Common stock has a Profit Margin of -2.6311%. This is 76.53% lower than that of the Health Care Technology sector and significantly lower than that of the Health Care industry. The profit margin for all United States stocks is 107.17% higher than that of the company.
iCoreConnect Common stock Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ICoreConnect's current stock value. Our valuation model uses many indicators to compare ICoreConnect value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ICoreConnect competition to find correlations between indicators driving ICoreConnect's intrinsic value. More Info.iCoreConnect Common stock is rated third overall in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ICoreConnect's earnings, one of the primary drivers of an investment's value.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
ICoreConnect Fundamentals
| Return On Equity | -17.18 | |||
| Return On Asset | -0.7 | |||
| Profit Margin | (2.63) % | |||
| Operating Margin | (0.79) % | |||
| Current Valuation | 15.62 M | |||
| Shares Outstanding | 2.07 M | |||
| Shares Owned By Insiders | 23.37 % | |||
| Shares Owned By Institutions | 2.77 % | |||
| Number Of Shares Shorted | 351.55 K | |||
| Price To Book | 8.91 X | |||
| Price To Sales | 0.35 X | |||
| Revenue | 8.15 M | |||
| Gross Profit | 8.57 M | |||
| EBITDA | (11.88 M) | |||
| Net Income | (15.55 M) | |||
| Cash And Equivalents | 164.26 K | |||
| Total Debt | 7.88 M | |||
| Current Ratio | 0.35 X | |||
| Book Value Per Share | (5.11) X | |||
| Cash Flow From Operations | (8.82 M) | |||
| Short Ratio | 0.01 X | |||
| Earnings Per Share | (63.20) X | |||
| Target Price | 0.5 | |||
| Number Of Employees | 67 | |||
| Beta | -0.71 | |||
| Market Capitalization | 3.86 M | |||
| Total Asset | 15.69 M | |||
| Retained Earnings | (115.04 M) | |||
| Working Capital | (5.37 M) | |||
| Net Asset | 15.69 M |
About ICoreConnect Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze iCoreConnect Common stock's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICoreConnect using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of iCoreConnect Common stock based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.iCoreConnect Inc., a cloud-based software and technology company, provides cloud-based software products for the healthcare sector in the United States. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. iCoreConnect Inc. was founded in 1992 and is headquartered in Ocoee, Florida. Vemics operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 55 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ICoreConnect Pink Sheet Analysis
When running ICoreConnect's price analysis, check to measure ICoreConnect's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICoreConnect is operating at the current time. Most of ICoreConnect's value examination focuses on studying past and present price action to predict the probability of ICoreConnect's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICoreConnect's price. Additionally, you may evaluate how the addition of ICoreConnect to your portfolios can decrease your overall portfolio volatility.